Filing Details

Accession Number:
0000711377-13-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-27 17:19:55
Reporting Period:
2013-09-25
Filing Date:
2013-09-27
Accepted Time:
2013-09-27 17:19:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-25 18,002 $19.55 46,577 No 4 M Direct
Common Stock Disposition 2013-09-25 18,002 $59.69 28,575 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2013-09-25 18,002 $0.00 18,002 $19.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
71,999 2014-08-24 No 4 M Direct
Footnotes
  1. Options were issued on 8/24/2009, vest 20% annually on the anniversary date of the grant, and expire on 8/24/2014